Hidden blood vessel damage may predict heart surgery complications
NCT ID NCT02965339
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study investigates whether patients with pre-existing endothelial dysfunction (damage to the inner lining of blood vessels) are more likely to develop vasoplegia (a dangerous drop in blood pressure) after cardiac surgery using a heart-lung machine. Researchers will measure various markers of endothelial function in adults undergoing coronary artery bypass or aortic valve surgery. The goal is to understand if pre-existing vessel damage contributes to post-surgery complications.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If a link is found, it could help identify patients at higher risk for complications after heart surgery, allowing for closer monitoring or preventive measures.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The results may not lead to changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU De Caen
Caen, Caen, 14000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill shield the brain and kidneys during heart surgery?
- Tiny particles in blood may signal hidden heart risk in hypertensive children
- Ancient herb gotu kola put to the test for healthier arteries in aging
- Could cocoa and veggies protect against pregnancy complications?
- Fatty meal test reveals hidden clues about blood vessel health
- New hope for heart bypass patients: drug targets dangerous low blood pressure